🎉 M&A multiples are live!
Check it out!

Medifast Valuation Multiples

Discover revenue and EBITDA valuation multiples for Medifast and similar public comparables like BIKE24, Temple & Webster, and Kogan.com.

Medifast Overview

About Medifast

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.


Founded

1989

HQ

United States of America
Employees

504

Website

medifastinc.com

Financials

LTM Revenue $570M

LTM EBITDA $36.8M

EV

$6.3M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Medifast Financials

Medifast has a last 12-month revenue of $570M and a last 12-month EBITDA of $36.8M.

In the most recent fiscal year, Medifast achieved revenue of $602M and an EBITDA of $15.6M.

Medifast expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Medifast valuation multiples based on analyst estimates

Medifast P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.1B $602M XXX XXX XXX
Gross Profit $1.1B $776M XXX XXX XXX
Gross Margin 106% 129% XXX XXX XXX
EBITDA $140M $15.6M XXX XXX XXX
EBITDA Margin 13% 3% XXX XXX XXX
Net Profit $144M $99.4M XXX XXX XXX
Net Margin 13% 17% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Medifast Stock Performance

As of March 14, 2025, Medifast's stock price is $14.

Medifast has current market cap of $152M, and EV of $6.3M.

See Medifast trading valuation data

Medifast Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$6.3M $152M XXX XXX XXX XXX $1.37

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Medifast Valuation Multiples

As of March 14, 2025, Medifast has market cap of $152M and EV of $6.3M.

Medifast's trades at 0.0x LTM EV/Revenue multiple, and 0.2x LTM EBITDA.

Analysts estimate Medifast's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Medifast and 10K+ public comps

Medifast Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $6.3M XXX XXX XXX
EV/Revenue 0.0x XXX XXX XXX
EV/EBITDA 0.4x XXX XXX XXX
P/E 72.9x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 0.4x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Medifast Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Medifast Valuation Multiples

Medifast's NTM/LTM revenue growth is -22%

Medifast's revenue per employee for the last fiscal year averaged $1.2M, while opex per employee averaged $0.9M for the same period.

Over next 12 months, Medifast's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Medifast's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Medifast and other 10K+ public comps

Medifast Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -44% XXX XXX XXX XXX
EBITDA Margin 3% XXX XXX XXX XXX
EBITDA Growth -89% XXX XXX XXX XXX
Rule of 40 (SaaS-only) -19% XXX XXX XXX XXX
Revenue per Employee $1.2M XXX XXX XXX XXX
Opex per Employee $0.9M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 73% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Medifast Public Comps

See public comps and valuation multiples for Consumer E-commerce and Vertical E-commerce comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Brillia Inc XXX XXX XXX XXX XXX XXX
Adore Beauty XXX XXX XXX XXX XXX XXX
Kogan.com XXX XXX XXX XXX XXX XXX
Temple & Webster XXX XXX XXX XXX XXX XXX
BIKE24 XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Medifast M&A and Investment Activity

Medifast acquired  XXX companies to date.

Last acquisition by Medifast was  XXXXXXXX, XXXXX XXXXX XXXXXX . Medifast acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Medifast

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Medifast

When was Medifast founded? Medifast was founded in 1989.
Where is Medifast headquartered? Medifast is headquartered in United States of America.
How many employees does Medifast have? As of today, Medifast has 504 employees.
Who is the CEO of Medifast? Medifast's CEO is Mr. Daniel R. Chard.
Is Medifast publicy listed? Yes, Medifast is a public company listed on NYS.
What is the stock symbol of Medifast? Medifast trades under MED ticker.
When did Medifast go public? Medifast went public in 1981.
Who are competitors of Medifast? Similar companies to Medifast include e.g. Brillia Inc, Adore Beauty, Kogan.com, Temple & Webster.
What is the current market cap of Medifast? Medifast's current market cap is $152M
What is the current revenue of Medifast? Medifast's last 12-month revenue is $570M.
What is the current EBITDA of Medifast? Medifast's last 12-month EBITDA is $36.8M.
What is the current EV/Revenue multiple of Medifast? Current revenue multiple of Medifast is 0.0x.
What is the current EV/EBITDA multiple of Medifast? Current EBITDA multiple of Medifast is 0.2x.
What is the current revenue growth of Medifast? Medifast revenue growth between 2023 and 2024 was -44%.
Is Medifast profitable? Yes, Medifast is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.